Belite Bio Inc ADR (BLTE)

NASDAQ
29.60
-1.17(-3.80%)
After Hours
29.60
0.00(0.00%)
- Real-time Data
  • Volume:
    47,295
  • Day's Range:
    29.12 - 31.00
  • 52 wk Range:
    8.80 - 44.70

BLTE Overview

Prev. Close
30.77
Day's Range
29.12-31
Revenue
-
Open
30.8
52 wk Range
8.8-44.7
EPS
-0.4
Volume
47,295
Market Cap
736.08M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
86,657
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
24,867,408
Next Earnings Date
Nov 30, 2022
What is your sentiment on Belite Bio ADR?
or
Market is currently closed. Voting is open during market hours.

Belite Bio Inc ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Belite Bio Inc ADR Company Profile

Belite Bio Inc ADR Company Profile

Employees
12

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Buy
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy